Skip to main content
main-content

Type 2 diabetes


Browse the latest news, expert commentary, and educational content on type 2 diabetes.


Highlights

07-15-2021 | Epidemiology | News

Global variation in optimal BMI, age cutoffs for diabetes screening

Researchers find large geographic differences in the influence of BMI and age on the risk for type 2 diabetes in low- and middle-income countries.

07-15-2021 | Glycemic control | News

Early second-line therapy response predicts sustained HbA1c reductions in type 2 diabetes

Early achievement of a glycated hemoglobin (HbA1c) level below 7% is a key factor in maintaining long-term glucose control in people with type 2 diabetes initiating second-line glucose-lowering therapy, DISCOVER study data show.

07-12-2021 | Ethnic groups | News

High CVD cost of ethnic statin prescribing disparities in type 2 diabetes

Reasons for ethnic disparities in statin prescribing in UK residents with type 2 diabetes are not clear, but may result in preventable atherosclerotic cardiovascular disease events, research suggests.

Semaglutide for weight loss: The STEP and SELECT trials

Get the latest results and insights from the researchers.

More on type 2 diabetes

View from the clinic: Sanjay Kalra

Expert insights on identifying appropriate patient profiles when considering the use of medication combinations.

SGLT2 inhibitor use in type 2 diabetes management

Learn about prescribing these medications with guidance from the Improving Diabetes Steering Committee.

  • » A prescribing tool to inform prescribing decisions for SGLT2 inhibitors
  • » SGLT2 inhibitors: Key evidence and implications for clinical practice
  • » Translating SGLT2 inhibitor cardiovascular evidence into practice
  • » This content is intended only for UK healthcare providers and was made possible by educational funding provided by Napp Pharmaceuticals Ltd.

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox

Image Credits